NEW YORK--(BUSINESS WIRE)--TransPerfect today announced that Pearl Therapeutics has implemented TransPerfect’s Trial Interactive electronic Trial Master File (eTMF) solution for the company’s clinical development programs. Trial Interactive is a secure web-based platform that eliminates the redundancies inherent in paper-based TMF studies. Trial Interactive complies with FDA’s 21 CFR Part 11 regulation which outlines the requirements for maintenance of electronic records.
